University Hospital, Martin

This study tests whether daratumumab can reduce microvascular inflammation in kidney transplant recipients. Twenty adults with signs of inflammation on biopsy will either receive daratumumab or standard monitoring. The goal is to see if the drug improves kidney health over 12 mon…